BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24756835)

  • 1. Next-generation sequencing: a change of paradigm in molecular diagnostic validation.
    Salto-Tellez M; Gonzalez de Castro D
    J Pathol; 2014 Sep; 234(1):5-10. PubMed ID: 24756835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations.
    Chin EL; da Silva C; Hegde M
    BMC Genet; 2013 Feb; 14():6. PubMed ID: 23418865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Noonan syndrome and related disorders using target next generation sequencing.
    Lepri FR; Scavelli R; Digilio MC; Gnazzo M; Grotta S; Dentici ML; Pisaneschi E; Sirleto P; Capolino R; Baban A; Russo S; Franchin T; Angioni A; Dallapiccola B
    BMC Med Genet; 2014 Jan; 15():14. PubMed ID: 24451042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
    Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
    Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
    J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of next-generation sequencing and mutation-specific platforms in clinical practice.
    Hinrichs JW; van Blokland WT; Moons MJ; Radersma RD; Radersma-van Loon JH; de Voijs CM; Rappel SB; Koudijs MJ; Besselink NJ; Willems SM; de Weger RA
    Am J Clin Pathol; 2015 Apr; 143(4):573-8. PubMed ID: 25780010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
    Shimazawa R; Ikeda M
    Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeq™ library and ion torrent PGM™ sequencing for the rapid detection of genetic variations in long QT syndrome.
    Millat G; Chanavat V; Rousson R
    Mol Diagn Ther; 2014 Oct; 18(5):533-9. PubMed ID: 24687331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel.
    Valencia CA; Ankala A; Rhodenizer D; Bhide S; Littlejohn MR; Keong LM; Rutkowski A; Sparks S; Bonnemann C; Hegde M
    PLoS One; 2013; 8(1):e53083. PubMed ID: 23326386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology.
    Zheng J; Zhang H; Banerjee S; Li Y; Zhou J; Yang Q; Tan X; Han P; Fu Q; Cui X; Yuan Y; Zhang M; Shen R; Song H; Zhang X; Zhao L; Peng Z; Wang W; Yin Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00748. PubMed ID: 31165590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
    Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
    Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
    Smith A; Boycott KM; Jarinova O
    Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory.
    Shahsiah R; DeKoning J; Samie S; Latifzadeh SZ; Kashi ZM
    Pathol Res Pract; 2017 Feb; 213(2):98-105. PubMed ID: 28049581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid identification of compound mutations in patients with Philadelphia-positive leukaemias by long-range next generation sequencing.
    Kastner R; Zopf A; Preuner S; Pröll J; Niklas N; Foskett P; Valent P; Lion T; Gabriel C
    Eur J Cancer; 2014 Mar; 50(4):793-800. PubMed ID: 24365090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of multi-objective optimization to pooled experiments of next generation sequencing for detection of rare mutations.
    Zilinskas J; Lančinskas A; Guarracino MR
    PLoS One; 2014; 9(9):e104992. PubMed ID: 25181462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer.
    Guan YF; Li GR; Wang RJ; Yi YT; Yang L; Jiang D; Zhang XP; Peng Y
    Chin J Cancer; 2012 Oct; 31(10):463-70. PubMed ID: 22980418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.